244 related articles for article (PubMed ID: 8530015)
21. The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells.
Mashour GA; Ratner N; Khan GA; Wang HL; Martuza RL; Kurtz A
Oncogene; 2001 Jan; 20(1):97-105. PubMed ID: 11244508
[TBL] [Abstract][Full Text] [Related]
22. Absence of cutaneous neurofibromas in an NF1 patient with an atypical deletion partially overlapping the common 1.4 Mb microdeleted region.
Kehrer-Sawatzki H; Schmid E; Fünsterer C; Kluwe L; Mautner VF
Am J Med Genet A; 2008 Mar; 146A(6):691-9. PubMed ID: 18265407
[TBL] [Abstract][Full Text] [Related]
23. Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions of the NF1 gene.
Colman SD; Williams CA; Wallace MR
Nat Genet; 1995 Sep; 11(1):90-2. PubMed ID: 7550323
[TBL] [Abstract][Full Text] [Related]
24. Identification of NF1 mutations in both alleles of a dermal neurofibroma.
Sawada S; Florell S; Purandare SM; Ota M; Stephens K; Viskochil D
Nat Genet; 1996 Sep; 14(1):110-2. PubMed ID: 8782831
[TBL] [Abstract][Full Text] [Related]
25. NF1 deletions in S-100 protein-positive and negative cells of sporadic and neurofibromatosis 1 (NF1)-associated plexiform neurofibromas and malignant peripheral nerve sheath tumors.
Perry A; Roth KA; Banerjee R; Fuller CE; Gutmann DH
Am J Pathol; 2001 Jul; 159(1):57-61. PubMed ID: 11438454
[TBL] [Abstract][Full Text] [Related]
26. Hereditary spinal neurofibromatosis: a rare form of NF1?
Poyhonen M; Leisti EL; Kytölä S; Leisti J
J Med Genet; 1997 Mar; 34(3):184-7. PubMed ID: 9132486
[TBL] [Abstract][Full Text] [Related]
27. A genetic study of neurofibromatosis type 1 (NF1) in south-western Ontario. II. A PCR based approach to molecular and prenatal diagnosis using linkage.
Rodenhiser DI; Ainsworth PJ; Coulter-Mackie MB; Singh SM; Jung JH
J Med Genet; 1993 May; 30(5):363-8. PubMed ID: 8320697
[TBL] [Abstract][Full Text] [Related]
28. Deletions spanning the neurofibromatosis 1 gene: identification and phenotype of five patients.
Kayes LM; Burke W; Riccardi VM; Bennett R; Ehrlich P; Rubenstein A; Stephens K
Am J Hum Genet; 1994 Mar; 54(3):424-36. PubMed ID: 8116612
[TBL] [Abstract][Full Text] [Related]
29. Molecular Analysis of Hybrid Neurofibroma/Schwannoma Identifies Common Monosomy 22 and α-T-Catenin/CTNNA3 as a Novel Candidate Tumor Suppressor.
Stahn V; Nagel I; Fischer-Huchzermeyer S; Oyen F; Schneppenheim R; Gesk S; Bohring A; Chikobava L; Young P; Gess B; Werner M; Senner V; Harder A
Am J Pathol; 2016 Dec; 186(12):3285-3296. PubMed ID: 27765635
[TBL] [Abstract][Full Text] [Related]
30. S100B and neurofibromin immunostaining and X-inactivation patterns of laser-microdissected cells indicate a multicellular origin of some NF1-associated neurofibromas.
Tucker T; Riccardi VM; Brown C; Fee J; Sutcliffe M; Vielkind J; Wechsler J; Wolkenstein P; Friedman JM
J Neurosci Res; 2011 Sep; 89(9):1451-60. PubMed ID: 21674567
[TBL] [Abstract][Full Text] [Related]
31. Biallelic somatic inactivation of the NF1 gene through chromosomal translocations in a sporadic neurofibroma.
Storlazzi CT; Von Steyern FV; Domanski HA; Mandahl N; Mertens F
Int J Cancer; 2005 Dec; 117(6):1055-7. PubMed ID: 15986446
[TBL] [Abstract][Full Text] [Related]
32. The effect of estradiol, testosterone, and human chorionic gonadotropin on the proliferation of Schwann cells with NF1
Pennanen P; Peltonen S; Kallionpää RA; Peltonen J
Mol Cell Biochem; 2018 Jul; 444(1-2):27-33. PubMed ID: 29185159
[TBL] [Abstract][Full Text] [Related]
33. Molecular, genetic, and cellular pathogenesis of neurofibromas and surgical implications.
Gottfried ON; Viskochil DH; Fults DW; Couldwell WT
Neurosurgery; 2006 Jan; 58(1):1-16; discussion 1-16. PubMed ID: 16385324
[TBL] [Abstract][Full Text] [Related]
34. A highly informative CA/GT repeat polymorphism in intron 38 of the human neurofibromatosis type 1 (NF1) gene.
Lázaro C; Gaona A; Xu G; Weiss R; Estivill X
Hum Genet; 1993 Oct; 92(4):429-30. PubMed ID: 8225327
[TBL] [Abstract][Full Text] [Related]
35. Chromosome 17p deletions and p53 gene mutations associated with the formation of malignant neurofibrosarcomas in von Recklinghausen neurofibromatosis.
Menon AG; Anderson KM; Riccardi VM; Chung RY; Whaley JM; Yandell DW; Farmer GE; Freiman RN; Lee JK; Li FP
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5435-9. PubMed ID: 2142531
[TBL] [Abstract][Full Text] [Related]
36. Whole Exome Sequencing of Growing and Non-Growing Cutaneous Neurofibromas from a Single Patient with Neurofibromatosis Type 1.
Faden DL; Asthana S; Tihan T; DeRisi J; Kliot M
PLoS One; 2017; 12(1):e0170348. PubMed ID: 28099461
[TBL] [Abstract][Full Text] [Related]
37. Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1.
Maertens O; De Schepper S; Vandesompele J; Brems H; Heyns I; Janssens S; Speleman F; Legius E; Messiaen L
Am J Hum Genet; 2007 Aug; 81(2):243-51. PubMed ID: 17668375
[TBL] [Abstract][Full Text] [Related]
38. Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.
Lévy P; Vidaud D; Leroy K; Laurendeau I; Wechsler J; Bolasco G; Parfait B; Wolkenstein P; Vidaud M; Bièche I
Mol Cancer; 2004 Jul; 3():20. PubMed ID: 15255999
[TBL] [Abstract][Full Text] [Related]
39. Differential expression of CCN1/CYR61, CCN3/NOV, CCN4/WISP1, and CCN5/WISP2 in neurofibromatosis type 1 tumorigenesis.
Pasmant E; Ortonne N; Rittié L; Laurendeau I; Lévy P; Lazar V; Parfait B; Leroy K; Dessen P; Valeyrie-Allanore L; Perbal B; Wolkenstein P; Vidaud M; Vidaud D; Bièche I
J Neuropathol Exp Neurol; 2010 Jan; 69(1):60-9. PubMed ID: 20010302
[TBL] [Abstract][Full Text] [Related]
40. High-resolution 400K oligonucleotide array comparative genomic hybridization analysis of neurofibromatosis type 1-associated cutaneous neurofibromas.
Asai A; Karnan S; Ota A; Takahashi M; Damdindorj L; Konishi Y; Hossain E; Konishi H; Nagata A; Yokoo K; Hosokawa Y
Gene; 2015 Mar; 558(2):220-6. PubMed ID: 25562418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
